FAM
HAE icon

Fred Alger Management’s Haemonetics HAE Stock Holding History

Fred Alger Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,956
Closed -$882K – 523
2022
Q1 		$882K Buy
+13,956
New +$759K ﹤0.01% 394
2019
Q4 		– Sell
-8,500
Closed -$1.07M – 498
2019
Q3 		$1.07M Buy
+8,500
New +$1.08M ﹤0.01% 327

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fred Alger Management's HAE Position: Q2 2022 in Review

Fred Alger Management sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 13,956 shares — an estimated $882K sold.

Fred Alger Management first reported a position in HAE in Q3 2019 and held it in 2 quarters. The position peaked at $1.07M in Q3 2019. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

  • Fred Alger Management reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 13,956 Haemonetics shares in Q2 2022, an estimated $882K.
  • Fred Alger Management first reported a position in Haemonetics in Q3 2019 and held it in 2 quarters.
  • Fred Alger Management's Haemonetics position peaked at $1.07M in Q3 2019.
  • 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.